Phio Pharma Analyst Ratings
Phio Pharma Analyst Ratings
While ratings are subjective and will change, the latest Phio Pharma (PHIO) rating was a reiterated with a price target of $0.00 to $6.00. The current price Phio Pharma (PHIO) is trading at is $2.29, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/16/2023 | 162.01% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy |
| 06/14/2021 | 162.01% | HC Wainwright & Co. | $4 → $6 | Maintains | Buy |
| 08/05/2020 | 74.67% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 08/16/2023 | 162.01% | HC Wainwright公司 | →$6 | 重申 | 购买→购买 |
| 2021/06/14 | 162.01% | HC Wainwright公司 | $4→$6 | 维护 | 买 |
| 08/05/2020 | 74.67% | HC Wainwright公司 | →$4 | 开始承保 | →购买 |
What is the target price for Phio Pharma (PHIO)?
PHIO Pharma(PHIO)的目标价是多少？
The latest price target for Phio Pharma (NASDAQ: PHIO) was reported by HC Wainwright & Co. on August 16, 2023. The analyst firm set a price target for $6.00 expecting PHIO to rise to within 12 months (a possible 162.01% upside). 1 analyst firms have reported ratings in the last year.
纳斯达克(PHIO Pharma)的最新目标价是由HC Wainwright&Co.于2023年8月16日报道的。这家分析公司将目标价定为6美元，预计PHIO将在12个月内上涨至(可能上涨162.01%)。1家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Phio Pharma (PHIO)?
PHIO Pharma(PHIO)的最新分析师评级是多少？
The latest analyst rating for Phio Pharma (NASDAQ: PHIO) was provided by HC Wainwright & Co., and Phio Pharma reiterated their buy rating.
PHIO Pharma(纳斯达克代码：PHIO)的最新分析师评级由HC Wainwright&Co.提供，PHIO Pharma重申其买入评级。
When is the next analyst rating going to be posted or updated for Phio Pharma (PHIO)?
PHIO Pharma(PHIO)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phio Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phio Pharma was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与PHIO Pharma的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。PHIO Pharma的上一次评级是在2023年8月16日提交的，所以你应该预计下一次评级将在2024年8月16日左右的某个时候公布。
Is the Analyst Rating Phio Pharma (PHIO) correct?
分析师对PHIO Pharma(PHIO)的评级正确吗？
While ratings are subjective and will change, the latest Phio Pharma (PHIO) rating was a reiterated with a price target of $0.00 to $6.00. The current price Phio Pharma (PHIO) is trading at is $2.29, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的PHIO Pharma(PHIO)评级被重申，目标价在0.00美元至6.00美元之间。PHIO Pharma(PHIO)目前的交易价格为2.29美元，在分析师的预测区间内。
